BackgroundCheck.run
Search For

William Sydney Wold, 801609 Adgers Wharf Dr, Wildwood, MO 63017

Known as:
William S Wold William A Wold William M Wold William S William Wold William Sm
Related to:
Josephine B Mcintyre 58 Jonathan E Wold 41 Loralee J Wold 53 Susan A Wold 75 Jessica A Wold 49 Madeline C Hellwig Sydney M Hellwig Robb E Hellwig 55

William Wold Phones & Addresses

1609 Adgers Wharf Dr, Chesterfield, MO 63017    636-5309399    636-5309957   

Saint Louis, MO   

Laurel, MT   

Work

Address: 1221 Locust St Ste 602, Saint Louis, MO 63103 Specialities: Criminal Defense - 100%

Ranks

Licence: Missouri - Good Standing, Active Date: 1997
Get Report
Control this profile

Mentions for William Sydney Wold

Career records & work history

Lawyers & Attorneys

William Wold Photo 1

William Guy Wold, Saint Louis MO - Lawyer

Address:
1221 Locust St Ste 602, Saint Louis, MO 63103
Licenses:
Missouri - Good Standing, Active 1997
Specialties:
Criminal Defense - 100%
William Wold Photo 2

William Wold - Lawyer

Office:
Law Office of Guy Wold
Specialties:
Criminal Law, Criminal Law - Appeals, Family Law, Family Law - Divorce, Family Law - Adoption, Family Law - Child Support/Visitation, Family Law - Paternity, Injury and Other Types of Torts (Wrongs) - Automobile Accidents, Injury and Other Types of Torts (Wrongs) - Personal Injury, Traffic Violations - DUI/DWI, Criminal Defense, Violent Crime, Criminal Defense, Personal Injury, Personal Injury
ISLN:
916331588
Admitted:
1997
University:
St. Louis University, B.A., 1994
Law School:
St. Louis University, J.D., 1997

William Wold resumes & CV records

Resumes

William Wold Photo 32

Owner

Location:
St, Louis, MO
Work:
Law Offices of Guy Wold
Owner
Education:
Saint Louis University School of Law
William Wold Photo 33

William Wold

William Wold Photo 34

William Wold

William Wold Photo 35

William Wold

Publications & IP owners

Us Patents

Adenovirus Replication-Competent Vectors Expressing Trail

US Patent:
2004021, Oct 28, 2004
Filed:
Mar 26, 2004
Appl. No.:
10/810063
Inventors:
William Wold - Chesterfield MO, US
Ann Tollefson - St. Louis MO, US
Baoling Ying - Ballwin MO, US
International Classification:
A61K048/00
C12N015/861
US Classification:
424/093200, 435/456000
Abstract:
The present invention provides replication-competent Adenoviral vectors that express TRAIL and ADP. In a particular aspect, TRAIL and/or ADP are highly expressed using the Adenovirus major late promoter or other promoter. Methods of treating hyperproliferative disorders using such vectors, alone or in combination with secondary therapies, also are described.

Models For Viral-Based Cancer Therapy

US Patent:
2005020, Sep 15, 2005
Filed:
Feb 14, 2005
Appl. No.:
11/057710
Inventors:
William Wold - Chesterfield MO, US
Karoly Toth - St. Louis MO, US
Maria Thomas - Crestwood MO, US
International Classification:
C12N015/861
A61K049/00
C12Q001/70
US Classification:
424009200, 435456000, 435005000
Abstract:
The present invention relates to the use of cotton rats and Syrian hamsters as models for adenoviral gene therapy. In particular, the models are directed to the examination of the ability of various replicative, non-replicative and conditionally-replicative adenovirus vectors to treat cancer.

Replication-Competent Anti-Cancer Vectors

US Patent:
2006002, Feb 9, 2006
Filed:
Oct 13, 2005
Appl. No.:
11/249873
Inventors:
William Wold - Chesterfield MO, US
Karoly Toth - St. Louis MO, US
Konstantin Doronin - St. Louis MO, US
Ann Tollefson - St. Louis MO, US
International Classification:
A61K 39/395
A61K 48/00
US Classification:
424130100, 424093200
Abstract:
Novel vectors which are replication competent in neoplastic cells and which overexpress an adenovirus death protein are disclosed. Some of the disclosed vectors are replication-restricted to neoplastic cells or to neoplastic alveolar type II cells. Compositions and methods for promoting the death of neoplastic cells using these replication-competent vectors are also disclosed.

Oncolytic Adenovirus Armed With Therapeutic Genes

US Patent:
2008029, Nov 27, 2008
Filed:
May 2, 2005
Appl. No.:
11/568499
Inventors:
Sunil Chada - Missouri City TX, US
William Wold - Chesterfield MO, US
Lou Zumstein - Del Mar CA, US
International Classification:
A61K 35/76
C12N 7/00
A61P 31/00
US Classification:
424 932, 4352351
Abstract:
The present invention involves compositions and methods for treating preventing cancer using compositions including replication competent adenovirus. The application competent adenovirus may or may not encode a therapeutic polynucleotide.

Replication-Competent Anti-Cancer Vectors

US Patent:
2010003, Feb 11, 2010
Filed:
Sep 16, 2009
Appl. No.:
12/561016
Inventors:
William S.M. Wold - Chesterfield MO, US
Karoly Toth - St. Louis MO, US
Konstantin Doronin - St. Louis MO, US
Ann E. Tollefson - St. Louis MO, US
International Classification:
A61K 35/76
C12N 15/00
C12N 5/07
US Classification:
424 932, 4353201, 435375
Abstract:
Novel vectors which are replication competent in neoplastic cells and which overexpress an adenovirus death protein are disclosed. Some of the disclosed vectors are replication-restricted to neoplastic cells or to neoplastic alveolar type II cells. Compositions and methods for promoting the death of neoplastic cells using these replication-competent vectors are also disclosed.

Recombinant Adenovirus Vectors That Are Replication-Competent In Tert-Expressing Cells

US Patent:
2002002, Mar 7, 2002
Filed:
Sep 19, 2001
Appl. No.:
09/956335
Inventors:
William Wold - Chesterfield MO, US
Karoly Toth - St. Louis MO, US
Ann Tollefson - St. Louis MO, US
Mohan Kuppuswamy - Ballwin MO, US
Assignee:
Saint Louis University
International Classification:
A61K048/00
C12N007/01
C12N015/861
US Classification:
514/044000, 424/093210, 435/320100, 435/235100
Abstract:
Novel adenovirus vectors which overexpress an adenovirus death protein and which are replication-competent in and, preferably, replication-restricted to cells expressing telomerase. One embodiment provides for efficient destruction and removal of viral-infected host cells expressing telomerase. Still further, another embodiment provides for additional restriction and safety by disrupting E1A's ability to bind p300 and/or members of the Rb family members. Compositions of the novel vectors and methods for promoting death of cells expressing telomerase with these vectors are also disclosed.

Possible Relatives

Cynthia W Wold  Dawn M Wold  Dean Wold  Aaron S Wold  Danielle J Wold  Dirk L Wold  Douglas R Wold  William V Johnson  William D Stamps  William N Stanberry 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.